Pfizer – Pre-clinical and translational research in multiple myeloma
Pfizer invites applications for its pre-clinical and translational research in multiple myeloma call. This supports pre-clinical projects with a focus on multiple myeloma. The following areas are of particular interest: •exploring the predictive impact of biological mechanisms in response or refractoriness to and relapse after anti-B-cell maturation antigen treatment; •preclinical predictive model and evaluation of […]
Pfizer – Pre-clinical and translational research in multiple myeloma Leggi tutto »